Plain-English translation of NCT05610956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether a medication called , when added to your regular ulcerative colitis medicines, can help reduce inflammation and symptoms better than standard treatment alone. Half of the 60 patients in the study will receive their usual medications (steroids, immune suppressors, and aminosalicylic acid), while the other half will also take daily. The study will run for 4 months to see if this medication helps.
Ulcerative colitis can be difficult to control even with current treatments, and researchers want to find additional options that might help reduce inflammation in the colon. This medication has shown promise in early research, and doctors want to learn whether adding it to standard treatment gives patients better results.
You likely qualify if…
You likely don't qualify if…
You will visit the study site at the beginning to have blood tests, a colonoscopy with biopsies, and a urine test to confirm your diagnosis and establish a baseline. Then, depending on which group you're randomly assigned to, you'll either continue your current medications or add the new medication to your routine for 4 months. At the end of 4 months, you'll return for repeat blood tests, colonoscopy, and other assessments to see how well the treatment worked.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt